Uses artificial intelligence and neural nets for drug discovery.
Homology modeling of proteins, high throughput virtual screening of databases, and the assessment of compounds
Adlai Nortye is a biopharmaceutical company discovering, developing and commercializing new drugs for cancer and metabolic diseases.
Proprietary Drug Discovery Platform
Atomwise is the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery.
Drug Discovery, Synthesis
Biotica develops endocannabinoid-based drug technologies.
Bridge Medicines is a fully funded, professionally staffed biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, ...
Contract Drug Discovery
Uses single-cell RNA sequencing to discover precision therapeutics for complex diseases such as autoimmunity and cancer.
Drug Discovery Software
The company provides a wide range of drug discovery, manufacturing, testing, and support services including: Animal models, Genetically Engineered Model Services, Drug discovery, Drug safety ...
Active pharmaceutical ingredients
Our XenoGene™ system enables the discovery of new products by linking the massive amount of "genomic" information generated over the past decade with the chemical compound libraries constructed ...
Small Molecule Discovery
Cyokinetics is focused on discovering and developing muscle activators as drug candidates for debilitating diseases.
DeepBiome Therapeutics works at the cutting edge of the microbiome, deep learning, and synthetic biology fields to build a new drug discovery platform.
Small Molecule discovery